INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Public company

LVTXLAVA Therapeutics NV

CIK 0001840748

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections4with evidence

LVTX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
OJ
Oliger Christy J.Director
LVTXLAVA Therapeutics NV
Disposition to issuer
D—
33.4K sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
  • ← Insider ofevidence
    Oliger Christy J.Director · Nov 17, 2025
  • ← Insider ofevidence
    Wadlinger Mary E.Director · Nov 17, 2025
  • ← Insider ofevidence
    Backstrom Jay T.Director · Nov 17, 2025
9
BT
Backstrom Jay T.Director
LVTXLAVA Therapeutics NV
Disposition to issuer
D
—
33.4K sh
Nov 13, 2025
Nov 17, 2025
traded Nov 13, 2025
+4d
SEC FORM 4

Evidence

9
WE
Wadlinger Mary E.Director
LVTXLAVA Therapeutics NV
Disposition to issuer
D—
33.4K sh
Nov 13, 2025Nov 17, 2025
traded Nov 13, 2025
+4dSEC FORM 4

Evidence

Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Source error

Price history for LVTX is unavailable.

An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.